Hypera Pharma

Director of Government Relations and Regulatory Affairs at Hypera Pharma and pharmacist specializing in Industrial Pharmacy and Clinical Pharmacology, she has over 20 years of experience in the pharmaceutical sector, working for national and multinational companies. Since 2018, she has held the position of Director of Government Relations at Hypera Pharma, where she is responsible for institutional relations with public authorities and regulatory strategies. Throughout her career, she has also stood out in industry organizations, reinforcing her leading role in the areas of public policy and pharmaceutical industry regulation.

Executive Director of Hypera Pharma's similar and generic business unit, where he leads the operations of the Neo Química brand. Under his management, Neo Química has consolidated its position as a leader in the Brazilian generic drug market, with sales of 461 million units in 2023, equivalent to 878 boxes per minute. leader in the Brazilian generic drug market, with sales of 461 million units in 2023, equivalent to 878 boxes per minute. In addition to his work at Hypera, he has distinguished himself in the pharmaceutical sector for his commitment to democratizing access to healthcare.